Imperial leads new consortium to study threats from new SARS-CoV-2 variants | Imperial News – Imperial College London

Imperial researchers will lead a new consortium of UK virologists to study the effects of emerging mutations in SARS-CoV-2.
The ‘G2P-UK’ National Virology Consortium will study how mutations in the pandemic virus affect how transmissible it is, the severity of COVID-19 it causes, and the effectiveness of vaccines and treatments.
The virus is constantly throwing up new variants and we need to gear up to assess the risk they pose.Prof. Wendy BarclayDepartment of Infectious Disease
Professor Wendy…

Click here to view the original article.